PPS exerts anti-tumor effects in the bladder cancer microenvironment by interfering with TLR-4, nitric oxide synthase (iNOS), and cyclooxygenase (COX)-2-regulated NF-κB (P65) signaling and stimulating macrophage polarization toward the M1 phenotype. This evidence concerns the gene NFKB1 and urinary bladder carcinoma.